DNA damage evaluated by comet assay in Mexican patients with type 2 diabetes mellitus. 2010

Emma Ibarra-Costilla, and Ricardo M Cerda-Flores, and Martha I Dávila-Rodríguez, and Adriana Samayo-Reyes, and Carmina Calzado-Flores, and Elva I Cortés-Gutiérrez
Unidad de Medicina Familiar No 46, Instituto Mexicano del Seguro Social, Monterrey, Mexico.

We conducted a case-control study to assess whether general DNA damage levels evaluated by comet assay (length of tail comet, tail extent moment, and olive tail moment) differ in Mexican patients with type 2 diabetes mellitus (DM2). The sample included 71 Mexican patients with DM2 who had developed the disease >5 years previously and had been treated with oral hypoglycemic drugs (sulfonylurea and/or metformin), with no microvascular or macrovascular complications. These patients were classified into three groups according to age: (I) 40-50 years, (II) 51-60 years, and (III) 61-70 years. A control group of 14 individuals (40-50 years) without DM2 was included. Our results showed there was a slight but not significant increase in DNA damage in the two groups of patients with DM2 aged between 40 and 60 years compared with the 61-70-year-old patient group and controls. In conclusion, given that general DNA damage was similar in the three groups of patients with DM2 and the control group, it is possible that these cells showed similar oxidative damage, as has been proposed previously.

UI MeSH Term Description Entries
D008297 Male Males
D008800 Mexico A country in NORTH AMERICA, bordering the Caribbean Sea and the Gulf of Mexico, between BELIZE and the UNITED STATES, and bordering the North Pacific Ocean, between Guatemala and the UNITED STATES.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control

Related Publications

Emma Ibarra-Costilla, and Ricardo M Cerda-Flores, and Martha I Dávila-Rodríguez, and Adriana Samayo-Reyes, and Carmina Calzado-Flores, and Elva I Cortés-Gutiérrez
August 2010, Analytical and quantitative cytology and histology,
Emma Ibarra-Costilla, and Ricardo M Cerda-Flores, and Martha I Dávila-Rodríguez, and Adriana Samayo-Reyes, and Carmina Calzado-Flores, and Elva I Cortés-Gutiérrez
September 2019, Mutagenesis,
Emma Ibarra-Costilla, and Ricardo M Cerda-Flores, and Martha I Dávila-Rodríguez, and Adriana Samayo-Reyes, and Carmina Calzado-Flores, and Elva I Cortés-Gutiérrez
September 1998, Mutation research,
Emma Ibarra-Costilla, and Ricardo M Cerda-Flores, and Martha I Dávila-Rodríguez, and Adriana Samayo-Reyes, and Carmina Calzado-Flores, and Elva I Cortés-Gutiérrez
June 2012, Breast (Edinburgh, Scotland),
Emma Ibarra-Costilla, and Ricardo M Cerda-Flores, and Martha I Dávila-Rodríguez, and Adriana Samayo-Reyes, and Carmina Calzado-Flores, and Elva I Cortés-Gutiérrez
September 1999, Toxicology letters,
Emma Ibarra-Costilla, and Ricardo M Cerda-Flores, and Martha I Dávila-Rodríguez, and Adriana Samayo-Reyes, and Carmina Calzado-Flores, and Elva I Cortés-Gutiérrez
January 2013, Methods in molecular biology (Clifton, N.J.),
Emma Ibarra-Costilla, and Ricardo M Cerda-Flores, and Martha I Dávila-Rodríguez, and Adriana Samayo-Reyes, and Carmina Calzado-Flores, and Elva I Cortés-Gutiérrez
January 2013, Genetic counseling (Geneva, Switzerland),
Emma Ibarra-Costilla, and Ricardo M Cerda-Flores, and Martha I Dávila-Rodríguez, and Adriana Samayo-Reyes, and Carmina Calzado-Flores, and Elva I Cortés-Gutiérrez
January 2016, PloS one,
Emma Ibarra-Costilla, and Ricardo M Cerda-Flores, and Martha I Dávila-Rodríguez, and Adriana Samayo-Reyes, and Carmina Calzado-Flores, and Elva I Cortés-Gutiérrez
June 2019, Microscopy (Oxford, England),
Emma Ibarra-Costilla, and Ricardo M Cerda-Flores, and Martha I Dávila-Rodríguez, and Adriana Samayo-Reyes, and Carmina Calzado-Flores, and Elva I Cortés-Gutiérrez
October 2004, Mutation research,
Copied contents to your clipboard!